BIVISION Trademark

Trademark Overview


On Sunday, August 20, 2023, a trademark application was filed for BIVISION with the United States Patent and Trademark Office. The USPTO has given the BIVISION trademark a serial number of 98141705. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 3, 2025. This trademark is owned by Bivision Pharmaceuticals(Nanjing),Inc.. The BIVISION trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic radiopharmaceutical agent for use in PET imaging; Diagnostic radiopharmaceutical preparations; Diagnostic reagents for medicinal use; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations for use in urology; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; Radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; Tumor suppressing agents
bivision

General Information


Serial Number98141705
Word MarkBIVISION
Filing DateSunday, August 20, 2023
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 3, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 28, 2024

Trademark Statements


Description of MarkThe mark consists of the stylized wording of "Bivision". The mark further consists of a stylized atom as the letter "O" in "Bivision".
Goods and ServicesDiagnostic radiopharmaceutical agent for use in PET imaging; Diagnostic radiopharmaceutical preparations; Diagnostic reagents for medicinal use; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations for use in urology; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; Radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; Tumor suppressing agents
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 19, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBivision Pharmaceuticals(Shanghai),Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressShanghai 200000
CN

Party NameBivision Pharmaceuticals(Nanjing),Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNanjing 200000
CN

Party NameBivision Pharmaceuticals(Shanghai),Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressShanghai 200000
CN

Party NameBivision Pharmaceuticals(Nanjing),Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNanjing 200000
CN

Trademark Events


Event DateEvent Description
Friday, August 25, 2023NEW APPLICATION ENTERED
Wednesday, September 20, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, April 18, 2024ASSIGNED TO EXAMINER
Friday, April 19, 2024EXAMINERS AMENDMENT -WRITTEN
Tuesday, September 19, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 19, 2024EXAMINERS AMENDMENT E-MAILED
Friday, April 19, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, April 19, 2024EXAMINER'S AMENDMENT ENTERED
Friday, April 19, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 8, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 28, 2024PUBLISHED FOR OPPOSITION
Tuesday, May 28, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 23, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 3, 2025ABANDONMENT - NO USE STATEMENT FILED
Monday, March 3, 2025ABANDONMENT - NO USE STATEMENT FILED
Monday, March 3, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 3, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED